Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024 at 06:47 AM EDT
Alzheimer's drug Leqembi brought in in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.
